Artelo biosciences presents positive pre-clinical results of art26.12, a novel fabp5 inhibitor, in alleviating chemotherapy-induced pain

Presentation delivered by professor saoirse o'sullivan at the 32nd annual icrs symposium in galway, ireland on sunday, june 26th presentation delivered by professor saoirse o'sullivan at the 32nd annual icrs symposium in galway, ireland on sunday, june 26th
ARTL Ratings Summary
ARTL Quant Ranking